Northwell Health acquires Synaptive Medical’s BrightMatter technology for complex brain tumor and spinal surgery
Synaptive Medical has announce that North Shore University Hospital, a member of Northwell Health, is the first center on Long Island to acquire the BrightMatter technology, an innovative solution of advanced imaging, planning, navigation, and robotics for complex brain tumor and spinal surgery.
“In our efforts to provide our patients with the absolutely latest technology and expertise, Northwell Health’s Neuroscience Institute and Cancer Institute are delighted to introduce Synaptive’s BrightMatter neurosurgical system to our area,” said Raj K. Narayan, MD, Northwell Health's senior vice president, neurosurgery service line.
“Being one of the first centers in the country to adopt this technology, we will now be able to approach tumors in the brain with visualization of details that will enable us to perform safer procedures and provide better outcomes.”
BrightMatter provides neurosurgeons with the latest advancements in visualization tools to perform minimally-invasive, patient-specific procedures.
Using an imaging method called diffusion tensor imaging, or DTI, BrightMatter uses tractography to automatically enhance MRI images of the entire brain’s pathways, allowing surgeons to see structures that can’t be seen with the naked eye and consider approaches for optimal navigation. This functionality may allow access to brain locations previously deemed inoperable.
With this information, surgeons can use Synaptive’s high-powered magnification system to view patient anatomy. This optical visualization system, mounted on a robotic arm, follows the surgeon’s tools and shows patient anatomy in unprecedented detail.
BrightMatter allows for better surgical ergonomics, facilitates collaboration with operating room staff, and consumes less surgical time without the need to manipulate cumbersome optics.
“With the addition of this state-of-the-art technology, we will not only offer our patients unique treatment options, but also conduct clinical oncology research for discovery of still better approaches as we go forward,” said George Raptis, MD, Northwell Health's senior vice president, cancer service line.
Synaptive is uniquely positioned to support Northwell Health’s commitment to be on the forefront of care through state-of-the-art technologies and innovative research.
“Collaborating with surgeons to better understand their challenges in the operating room is deeply rooted in Synaptive’s culture,” said Cameron Piron, Synaptive’s president.
Source: Company Press Release